AstraZeneca 'ahead of schedule' in development of personalised medicines
This article was originally published in Scrip
Executive Summary
AstraZeneca has beat a self-imposed target of having half of the product candidates in its portfolio associated with patient stratification tools by about three years, its head of personalised management Dr Robert Holland has told Scrip.